Skip to main content
Sign In

Welcome to the Department of Emergency Medicine at the University of Colorado School of Medicine.

Emergency Medicine Banner Image
 

Andrew Monte, MD


​​​University of Colorado School of Medicine

Associate Professor of Emergency Medicine

 
Contact information

Anschutz Medical Campus​
Leprino Building, Campus Box B215
12401 East 17th Avenue​

Aurora, CO 80045
720-848-6777
Andrew.Monte@ucdenver.edu

 
Dr. Monte's primary research interest is in personalized medicine. He focuses on predicting medication efficacy and safety using genomic and metabolomic techniques. Dr. Monte’s toxicology research focuses on epidemiology and ethnography of novel drugs of abuse, opioid toxicity, and marijuana use.
Institution​
Degree Year ​Focus
University of Vermont, Burlington, VT B.S. 2000 ​Biology
University of Massachusetts Medical School, Worcester, MA M.D. 2005 ​Doctor of Medicine
University of Massachusetts, Worcester, MA 2008 Emergency Medicine Residency
​Rocky Mountain Poison & Drug Center, Denver, CO 2011​ ​Toxicology Fellowship

Funded Projects

 

  • An Integrated Approach to Personalized Medicine    
    Role: Principal Investigator (PI) & Grant Writer
    Funding Agency: National Institutes of Health - General Medical Sciences
    Funding Period: September 2014 - August 2018
    Aim: This research project integrates clinical, genomic, cytochrome metabolism phenotype, and metabolomic factors to develop a model that predicts systolic blood pressure decline due to metoprolol.

 

  • Genotype-Phenotype Discordance in Elderly Polypharmacy Patients    
    Role: Principal Investigator (PI) & Grant Writer
    Funding Agency: University of Colorado - Department of Emergency Medicine
    Funding Period: April 2014 - Projection Completion
    Aim: The goal of this research projects is to Utilize genotyping and phenotyping of the drug-metabolizing enzyme cytochrome 2D6 (CYP2D6) to improve drug therapy in polypharmacy patients. 

 

  • Genotype-Phenotype Discordance in Elderly Polypharmacy Patients    
    Role: Principal Investigator (PI) & Grant Writer
    Funding Agency: John A. Hartford Foundation for Aging Research
    Funding Period: January 2012 - Projection Completion
    Aim: The goal of this research projects is to Utilize genotyping and phenotyping of the drug-metabolizing enzyme cytochrome 2D6 (CYP2D6) to improve drug therapy in polypharmacy patients. 

 

  • Genotype-Phenotype Discordance in Elderly Polypharmacy Patients    
    Role: Principal Investigator (PI) & Grant Writer
    Funding Agency: University of Colorado - Clinical Translational Research Center
    Funding Period: January 2012 - Projection Completion
    Aim: The goal of this research projects is to Utilize genotyping and phenotyping of the drug-metabolizing enzyme cytochrome 2D6 (CYP2D6) to improve drug therapy in polypharmacy patients. 

 

  • Hepatic Cytochrome Drug Interactions in Emergency Department Patients
    Role: Principal Investigator (PI) & Grant Writer
    Funding Agency: Emergency Medicine Foundation (EMF)
    Funding Period: July 2012- June 2014
    Aim: The examination of mechanisms of genomic-medication interactions in ED patients, specifically interactions due to the drug metabolizing enzymes hepatic cytochrome 2D6 (CYP2D6) to improve medication efficacy and safety for ED patients.

 

 
Other Projects
 
 
View All PubMed Publications

 

Selected Publications (13 out of 25)

  • Monte AA, Mandell T, Wilford BB, Tennyson J, Boyer EW. Diversion of buprenorphine/naloxone coformulated tablets in a region with high prescribing prevalence. Journal of addictive diseases 2009;28:226-31.
 
  • Monte AA, Chuang R, Bodmer M. Dextromethorphan, chlorphenamine and serotonin toxicity: case report and systematic literature review. British journal of clinical pharmacology 2010;70:794-8.
 
  • , Monte AA, Kokko J, Yin S. Safety of non-therapeutic levetiracetam ingestions -a poison center based study. Pharmacoepidemiology and drug safety 2011;20:366-9.
 
  • Monte AA, Bucher-Bartelson B, Heard KJ. A US perspective of symptomatic Latrodectus spp. envenomation and treatment: a National Poison Data System review. The Annals of pharmacotherapy 2011;45:1491-8.
 
  • Hoyte CO, Jacob J, Monte AA, Al-Jumaan M, Bronstein AC, Heard KJ. A characterization of synthetic cannabinoid exposures reported to the National Poison Data System in 2010. Annals of emergency medicine 2012;60:435-8.
 
  • Monte AA. Black widow spider (Latrodectus mactans) antivenom in clinical practice. Current pharmaceutical biotechnology 2012;13:1935-9.
 
  • Monte AA, Heard KJ, Vasiliou V. Prediction of drug response and safety in clinical practice. Journal of medical toxicology : official journal of the American College of Medical Toxicology 2012;8:43-51.
 
  • Monte AA, Vasiliou V, Heard KJ. Omics Screening for Pharmaceutical Efficacy and Safety in Clinical Practice. Journal of pharmacogenomics & pharmacoproteomics 2012;S5.
 
  • Monte AA. Drug safety in the 'omics era. Drug Metab Toxicol 2013;4.
 
  • Monte AA, Ceschi A, Bodmer M. Safety of non-therapeutic atomoxetine exposures--a national poison data system study. Human psychopharmacology 2013;28:471-6.
 
  • Monte AA, Brocker C, Nebert DW, Gonzalez FJ, Thompson DC, Vasiliou V. Improved drug therapy: triangulating phenomics with genomics and metabolomics. Human genomics 2014;8:16.
 
  • Monte AA, Heard KJ, Campbell J, Hamamura D, Weinshilboum RM, Vasiliou V. The Effect of CYP2D6 Drug-Drug Interactions on Hydrocodone Effectiveness. Academic emergency medicine : official journal of the Society for Academic Emergency Medicine 2014;21:879-85.
 
  • Monte AA, Heard KJ, Hoppe JA, Vasiliou V, Gonzalez FJ. The accuracy of self-reported drug ingestion histories in emergency department patients. Journal of clinical pharmacology 2014.
Dr. Monte has been interviewed on Rocky Mountain PBS, The Dr. Oz Show, MSNBC, CBS, numerous radio and other news outlets for his work on drugs of abuse.

  • Emergency Medicine Preceptor of Year - Nominee, University of Colorado School of Medicine, Foundations of Doctoring, May 2014, 2012
  • John A. Hartford Geriatrics Scholar, John A. Hartford Foundation, July 2012
  • Teacher of the Year, University of Massachusetts Medical School, Department of Emergency Medicine, June 2008
  • Award for Excellence in Emergency Medicine, Society for Academic Emergency Medicine, May 2005
  • Student Educator Award, University of Massachusetts Medical School, May 2005
  • Award for Excellence in Primary Care, University of Massachusetts Medical School, May 2003